LOGIN
Shockwave Therapy vs. Celecoxib for Hip Pain from Femoral Head Necrosis
May 2023
Shockwave Therapy vs. Celecoxib for Hip Pain from Femoral Head Necrosis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Effects of individual shock wave therapy vs celecoxib on hip pain caused by femoral head necrosis.
World J Clin Cases. 2023 Mar 26;11(9): 1974-1984.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
72 patients with osteonecrosis of the femoral head were randomized to receive 5 sessions of extracorporeal shockwave therapy guided by MRI-3D reconstruction (n=36) or 9 days of celecoxib with sham shockwave therapy (n=36). All patients received alendronate in addition to study interventions. The primary outcome of interest was treatment efficacy after the 2nd week of treatment (Harris Hip Score [H...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.